+49 751 37000
Vetter – Your partner in clinical & commercial manufacturing and packaging. Offering Drug Development, Fill and Finish, and CDMO services.
Vetter is a global leading contract development and manufacturing organisation (CDMO) headquartered in Ravensburg with production facilities in Germany, Austria and the US and an international specialist in the production of aseptically pre-filled syringe systems, cartridges and vials.
We are a family-owned, independent company and do not manufacture our own drugs.
With years of experience and the dedication of our employees, we support companies from early process development through clinical and commercial filling to a wide variety of packaging solutions for vials, syringes and cartridges.
As a provider of innovative solutions, we have made it our mission to work with our clients to develop injection systems for the continuous improvement of patient safety, comfort and compliance. We are committed to the principles of sustainability and act as a corporate citizen in a socially and ethically responsible manner.
Tap into the knowledge of specialists with decades of experience identifying and solving difficult challenges. From technical obstacles such as siliconisation and lyophilisation to strategic issues such as life cycle planning, Vetter’s integrated team approach brings together the right experts for your compound’s precise requirements.
This kind of expertise is at the heart of what makes a CDMO a valuable partner for your injectable. When you consider all the criteria your outsourcing partner should meet – experience with a broad range of injectables, deep scientific and manufacturing resources, financial stability, and even a commonly shared vision – a partner whose expertise goes above and beyond clearly stands out.
Our customers represent the entire range of small to large companies in the pharmaceutical and biotechnological industries.
If you have further questions, please contact us www.vetter-pharma.com/en/contact/service-inquiries
For general information, please visit www.vetter-pharma.com
We are proud to announce that our #collaboration with Rentschler Biopharma SE has made significant progress and an established framework for our alliance has been further strengthened! #cdmo #drugdevelopmenthttps://t.co/6WxHvXtXvS pic.twitter.com/kfRDuieEAY— Vetter Pharma (@vetterpharma) April 28, 2021
Want to learn how medication trends are driving the shift to patient-friendly delivery systems? In this concise article, Managing Director Peter Soelkner clues you in. #CDMO #injectables https://t.co/6nZb32pYhj— Vetter Pharma (@vetterpharma) March 9, 2021